Abstract:Benign epilepsy with centrotemporal spikes (BECTS) is the most common epilepsy syndrome and the aetiology is unclear, but recent epidemiological research has suggested that it is a neurological disorder with a strong genetic basis.1 We recruited a pair of twins, only one of which exhibited BECTS. The proband was an 11-year-old girl diagnosed with BECTS. Her first reported symptoms were seizures at the age of 9 years and sudden loss of consciousness followed by tonic–clonic movements of the extremities lasting 10 min. Electroencephalogram showed bilateral centrotemporal spikes with electrical status epilepticus during sleep. Whole-exome sequencing was performed on the proband, her normal twin sister and their parents. A de novo heterozygous variant in KCNT1, p.R1061Q, was found, which was further confirmed by Sanger sequencing. The KCNT1 gene belongs to a large family of genes encoding potassium channels. The missense variant p.R1061Q leads to a change from arginine to glutamic acid at residue 1061, and was predicted to damage the protein function of KCNT1. The analysis of the twin sisters and the family-based whole-exome sequencing helped us to quickly narrow down the list of candidate variants associated with BECTS. KCNT1 mutation can lead to different forms of epilepsy,2 which may be related to the location of the mutation. We found that the mutation was located at the 1061st amino acid near the C-terminus, which has not previously been reported in epilepsy patients. However, the 1106th amino acid, or c.3317G>A, p.Arg1106Gln, was reported to be associated with Brugada syndrome, a cardiac disorder comorbidity for epilepsy.3 Moreover, Tiron et al. found that long QT syndrome, a congenital disorder characterised by prolongation of the QT interval on electrocardiograms, coexists with epilepsy, which is associated with mutation in KCNQ1, which like KCNT1 belongs to the potassium ion channel group of genes.2 Understanding the patient's genetic background should be beneficial for precisely choosing the most appropriate treatment. Studies have shown the promise of quinidine as a targeted intervention for patients with KCNT mutations.4 Further clinical trials of quinidine treatment in patients with KCNT1 mutations in BECTS are also necessary, and in-depth functional studies will be necessary to determine the pathogenic role of KNCT1 in BECTS. This project was supported by the National Natural Science Foundation of China (programme nos. 81500974, 81701351, 81471329 and 81720108018) and Shenzhen Science Technology and Innovation Commission (programme nos. JCYJ20160429174706491 and JCYJ20170413093358429).

An intronic variant in BRAT1 creates a cryptic splice site, causing epileptic encephalopathy without prominent rigidity

Novel Biallelic Variant in the BRAT1 Gene Caused Nonprogressive Cerebellar Ataxia Syndrome

Novel BRAT1 Deep Intronic Variant Affects Splicing Regulatory Elements Causing Cerebellar Hypoplasia Syndrome: Genotypic and Phenotypic Expansion

Novel Variant in BRAT1 with the Lethal Neonatal Rigidity and Multifocal Seizure Syndrome

BRAT1-related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Autosomal Dominant Sleep-Related Hypermotor Epilepsy Associated with a Novel Mutation of KCNT1.

Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Psychomotor development and attention problems caused by a splicing variant of CNKSR2

De Novo Pathogenic Variant in FBRSL1, Non OMIM Gene Paralogue AUTS2, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the Literature

Two novel variants of the STXBP1 and CHRNB2 genes identified in a Chinese boy with refractory seizures and developmental delay

Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report

Role of TRAK1 variants in epilepsy: genotype–phenotype analysis in a pediatric case of epilepsy with developmental disorder

Discovery of a Novel Shared Variant Among RTEL1 Gene and RTEL1-TNFRSF6B lncRNA at Chromosome 20q13.33 in Familial Progressive Myoclonus Epilepsy

Clinical and Molecular Characterization of Three Novel ARHGEF9 Mutations in Patients with Developmental Delay and Epilepsy

Whole‐Exome Sequencing Revealing De Novo Heterozygous Variant OF KCNT1 in a Twin Discordant for Benign Epilepsy with Centrotemporal Spikes

Complex structural variation and nonsense variant in trans cause VPS50-related disorder

Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability.

A milder form of NSRP1‐associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects